SG11201806091YA - Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation - Google Patents

Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation

Info

Publication number
SG11201806091YA
SG11201806091YA SG11201806091YA SG11201806091YA SG11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA
Authority
SG
Singapore
Prior art keywords
international
rule
new york
formulation
new jersey
Prior art date
Application number
SG11201806091YA
Other languages
English (en)
Inventor
Tushar Hingorani
Sasank Chaitanya Kunadharaju
Tushar Malkan
Satish Pejaver
Original Assignee
Innopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innopharma Inc filed Critical Innopharma Inc
Publication of SG11201806091YA publication Critical patent/SG11201806091YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2/06—Hot gas
    • A61L2/07—Steam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/18—Aseptic storing means
    • A61L2202/181—Flexible packaging means, e.g. permeable membranes, paper
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/23—Containers, e.g. vials, bottles, syringes, mail

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201806091YA 2016-02-05 2017-01-23 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation SG11201806091YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662291589P 2016-02-05 2016-02-05
PCT/IB2017/050341 WO2017134540A1 (en) 2016-02-05 2017-01-23 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation

Publications (1)

Publication Number Publication Date
SG11201806091YA true SG11201806091YA (en) 2018-08-30

Family

ID=57915030

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806091YA SG11201806091YA (en) 2016-02-05 2017-01-23 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation

Country Status (21)

Country Link
US (3) US20190029979A1 (zh)
EP (1) EP3411004B1 (zh)
JP (1) JP2019506407A (zh)
KR (1) KR102246136B1 (zh)
CN (1) CN108601704A (zh)
AU (2) AU2017215419B2 (zh)
BR (1) BR112018014354A2 (zh)
CA (1) CA3013413C (zh)
CY (1) CY1124008T1 (zh)
DK (1) DK3411004T3 (zh)
ES (1) ES2867392T3 (zh)
HU (1) HUE053952T4 (zh)
IL (1) IL260320B (zh)
MX (1) MX2018009497A (zh)
PL (1) PL3411004T3 (zh)
PT (1) PT3411004T (zh)
RU (1) RU2729528C2 (zh)
SG (1) SG11201806091YA (zh)
SI (1) SI3411004T1 (zh)
WO (1) WO2017134540A1 (zh)
ZA (1) ZA201804970B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10052296B2 (en) 2016-04-07 2018-08-21 Nevakar Inc. Formulations for treating pain
CN111432882A (zh) * 2017-10-03 2020-07-17 内瓦卡公司 对乙酰氨基酚-普瑞巴林组合和治疗疼痛的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314405A (en) * 1992-04-17 1994-05-24 Science Incorporated Liquid delivery apparatus
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
CA2628806C (en) * 2006-07-18 2012-08-21 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
CN101522223A (zh) * 2006-07-20 2009-09-02 西科尔公司 固体无菌活性药物成分的制备方法
RU2010110393A (ru) * 2010-03-18 2011-09-27 Биотекуе Корпоратион (CN) Экологически безопасный мягкий пакет для инфузионного раствора
EP2377516B1 (en) * 2010-04-14 2012-06-20 B. Braun Melsungen AG Acetaminophen composition
DE202011102490U1 (de) * 2011-04-07 2012-06-28 Klosterfrau Berlin Gmbh Sterilisation von medizinischen Instrumenten für die Injektion und/oder Instillation
KR101966830B1 (ko) * 2012-05-09 2019-04-08 아이크롬 에스피에이 무균 활성 약제 성분의 제조 방법
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US8835505B1 (en) * 2013-03-15 2014-09-16 Welgrace Research Group Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
US20140303254A1 (en) 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
WO2016013049A1 (en) * 2014-07-25 2016-01-28 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation

Also Published As

Publication number Publication date
CA3013413C (en) 2020-12-01
PL3411004T3 (pl) 2021-10-18
AU2017215419A1 (en) 2018-07-19
JP2019506407A (ja) 2019-03-07
MX2018009497A (es) 2019-05-06
AU2019257508B2 (en) 2020-12-24
RU2018128397A3 (zh) 2020-03-05
BR112018014354A2 (pt) 2018-12-18
US20220023238A1 (en) 2022-01-27
ES2867392T3 (es) 2021-10-20
AU2017215419B2 (en) 2019-11-21
EP3411004B1 (en) 2021-03-10
KR20180100615A (ko) 2018-09-11
CA3013413A1 (en) 2017-08-10
PT3411004T (pt) 2021-05-11
DK3411004T3 (da) 2021-04-19
IL260320A (en) 2018-08-30
IL260320B (en) 2021-10-31
AU2019257508A1 (en) 2019-11-21
ZA201804970B (en) 2019-05-29
RU2018128397A (ru) 2020-03-05
CY1124008T1 (el) 2022-05-27
HUE053952T2 (hu) 2021-08-30
SI3411004T1 (sl) 2021-08-31
RU2729528C2 (ru) 2020-08-07
CN108601704A (zh) 2018-09-28
EP3411004A1 (en) 2018-12-12
HUE053952T4 (hu) 2021-09-28
WO2017134540A1 (en) 2017-08-10
US20190029979A1 (en) 2019-01-31
US20200330411A1 (en) 2020-10-22
KR102246136B1 (ko) 2021-04-29

Similar Documents

Publication Publication Date Title
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201810116VA (en) Exosomes comprising therapeutic polypeptides
SG11201811338VA (en) A novel botulinum neurotoxin and its derivatives
SG11201804384UA (en) Geometric configurations for gastric residence systems
SG11201908740VA (en) Sustained release delivery systems comprising traceless linkers
SG11201408174UA (en) Antibody formulation
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201900443VA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201804263PA (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
SG11201903326RA (en) Liposomal formulation for use in the treatment of cancer
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201408511QA (en) Liquid preparations of amines and organic acids stabilized by salts
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201803949RA (en) Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
SG11201805771XA (en) Systems and methods for preparation of platelets
SG11201805755SA (en) Methods of administering hepcidin
SG11201811712QA (en) 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201909735YA (en) Therapeutic compounds and compositions, and methods of use thereof
SG11201811221XA (en) Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof
SG11201810940XA (en) Methods of treating pancreatic cancer
SG11201903145TA (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone